NOS3 Gene Polymorphism and Prostate Cancer Progression
Author Information
Author(s): Karina Marangoni, Thaíse G Araújo, Adriana F Neves, Luiz R Goulart
Primary Institution: Federal University of Uberlândia
Hypothesis
The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression.
Conclusion
The -786T>C polymorphism is linked to increased NOS3 transcript levels and may influence prostate cancer progression.
Supporting Evidence
- Three novel SNPs were identified in the NOS3 gene promoter region.
- NOS3 levels higher than 80% of the constitutive gene expression level presented a 4-fold increase in PCa occurrence.
- The incorporation of the C allele is associated with increased levels of NOS3 transcripts.
Takeaway
This study found that a specific change in a gene related to nitric oxide can help predict how prostate cancer might grow.
Methodology
The study used PCR-SSCP and sequencing to analyze NOS3 polymorphisms and their association with gene expression in blood samples from patients.
Potential Biases
Potential misdiagnosis in BPH patients due to biopsy sampling errors.
Limitations
The ethnic background of participants was not recorded due to the heterogeneous nature of the Brazilian population.
Participant Demographics
177 patients, including 83 with prostate cancer (PCa) and 94 with benign prostatic hyperplasia (BPH), with a mean age of 69 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
CI95%, 0.95 – 16.77
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website